3,5-dimethyl-4-(6-methylpyridin-3-yl)isoxazol

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 3,5-dimethyl-4-(6-methylpyridin-3-yl)isoxazol
• 英文别名: 3,5-Dimethyl-4-(6-methylpyridin-3-yl)-1,2-oxazole；3,5-dimethyl-4-(6-methylpyridin-3-yl)-1,2-oxazole
• 化学式: C₁₁H₁₂N₂O
• 分子量: 188.229
• InChiKey: XTKXCESGTGROKM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.27
• 拓扑面积：
  38.9
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  3,5-二甲基异唑 、 5-溴-2-甲基吡啶 在 C₆₈H₆₅Cl₂N₃Pd 、 potassium carbonate 、 三甲基乙酸 作用下， 以 N,N-二甲基乙酰胺 为溶剂， 反应 12.0h， 以96%的产率得到3,5-dimethyl-4-(6-methylpyridin-3-yl)isoxazol
  参考文献：
  名称：

  Developing Bis(imino)acenaphthene-Supported N-Heterocyclic Carbene Palladium Precatalysts for Direct Arylation of Azoles

  摘要：

  On the basis of the strategy of developing highly efficient protocol for Pd-catalyzed cross-coupling reactions, a series of bulky bis(imino)acenaphthene (BIAN)-supported Pd-PEPPSI complexes were synthesized, characterized, and applied in direct arylation of azoles. The effect of backbone and N-moieties on NHCs was evaluated, and the reaction conditions were optimized. It was found that the bulky Pd-PEPPSI complexes could be successfully employed in cross-coupling of (hetero)aryl bromides with azoles at a low palladium loading of 0.5-0.05 mol % under aerobic conditions, demonstrating the ease of manipulation without glovebox and handling of solvents.

  DOI：

  10.1021/acs.organomet.7b00784

文献信息

• Novel Heterocyclic Compounds as Bromodomain Inhibitors
  申请人：Liu Shuang

  公开号：US20140179648A1

  公开（公告）日：2014-06-26

  The present disclosure relates to compounds, which are useful for inhibition of BET protein function by binding to bromodomains, and their use in therapy.

  本公开涉及一些化合物，这些化合物通过结合溴结构域对BET蛋白功能进行抑制，并且它们在治疗中的应用。
• NOVEL HETEROCYCLIC COMPOUNDS AS BROMODOMAIN INHIBITORS
  申请人：Zenith Epigenetics Ltd.

  公开号：US20170143731A1

  公开（公告）日：2017-05-25

  The present disclosure relates to compounds, which are useful for inhibition of BET protein function by binding to bromodomains, and their use in therapy.
• US9271978B2
  申请人：——

  公开号：US9271978B2

  公开（公告）日：2016-03-01
• US9598367B2
  申请人：——

  公开号：US9598367B2

  公开（公告）日：2017-03-21
• US9861637B2
  申请人：——

  公开号：US9861637B2

  公开（公告）日：2018-01-09